Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator.
Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions.
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS.
Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS.
Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventories.
Mitoxantrone: benefits and risks in multiple sclerosis patients.
Tolerability and Pulmonary Pharmacodynamic Effects During Treatment Initiation of Once-Daily Oral Fingolimod in Subjects With Moderate Asthma.
Current and future immunotherapy targets in autoimmune neurology.
Protective effects of monomethyl fumarate at the inflamed blood-brain barrier.
Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years.
Myelin Gordon Research Conference
Headache in relapse and remission phases of multiple sclerosis: A case-control study.
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.
Genpharm and Genzyme Aubagio ® agreement for the MENA region
Ethnicity and prevalence of multiple sclerosis in east London.
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, non-randomized pilot study.
Persistency of neutralizing antibodies depends on titer and interferon-beta preparation.
Interferon-beta is a potent promoter of nerve growth factor production by astrocytes.
Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
Optical coherence tomography and neurodegeneration: are eyes the windows to the brain?
Neuroimmunology: Clostridium-reactive T cells are implicated in the pathogenesis of neuromyelitis optica.
Radiologically isolated syndrome: 5-year risk for an initial clinical event.
Copaxone
Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients.
Multiple sclerosis and risk of young-adult-onset Hodgkin lymphoma.
Pages
« first
‹ previous
…
86
87
88
89
90
91
92
93
94
…
next ›
last »